Clinical Trials on Benign Breast Findings in New Zealand

Total 2234 results

Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

Breast Cancer

United States
New York Presbyterian Hospital

Unknown

Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women

Breast Cancer

United States
Montefiore Medical Center
Albert Einstein College of Medicine; Deciphera Pharmaceuticals LLC

Terminated

Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Breast Adenocarcinoma

United States
Advanced Imaging Projects, LLC
All India Institute of Medical Sciences, New Delhi; US Department of Veterans... and other collaborators

Not yet recruiting

Safety and Efficacy of Ga68 Αvβ3 IAC PET/CT for Diagnosis and Clinical Management in Angiogenic Breast Cancer Patients (Shiva)

Angiogenic Breast Cancer

South Africa, India
Memorial Sloan Kettering Cancer Center
Duke University

Completed

Aerobic Training in Metastatic Breast Cancer (Breast Mets)

Metastatic Breast Cancer

United States
Novartis Pharmaceuticals

Terminated

Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).

Triple Negative Breast Cancer (TNBC)

Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
LUTRONIC Corporation

Terminated

Lutronic PicoPlus Exploratory Clinical Trial

Melasma | Tattoo; Pigmentation | Benign Pigmented Lesion

United States
National Cancer Institute (NCI)

Completed

Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma

United States
Eileen Connolly
Merck Sharp & Dohme LLC

Recruiting

Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer (Pembro/IORT)

Triple Negative Breast Cancer

United States
PharmAbcine

Active, not recruiting

TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer

Triple Negative Breast Cancer

Australia
Novartis Pharmaceuticals

Completed

Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors

Metastatic Breast Cancer

United States
Novartis Pharmaceuticals

Completed

A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors

Metastatic Breast Cancer

United States
PTC Therapeutics
United States Department of Defense

Completed

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Breast Cancer | Lymphedema | Lymphedema of Upper Arm | Breast Carcinoma | Lymphedema Arm | Female Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of the Use of Text Message Reminders to Take Palbociclib

Breast Cancer

United States
Cairo University
Theodor Bilharz Research Institute; National Hepatology & Tropical Medicine...

Unknown

Kaffes Stent in the Management of Post-surgical Biliary Strictures

Cholangitis | Biliary Stricture | Bile Duct Injury | Bile Duct Stricture | Benign Biliary Stricture

Egypt
Memorial Sloan Kettering Cancer Center
Yale University; Weill Medical College of Cornell University; New York Presbyterian...

Recruiting

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Novartis

Completed

Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline

Completed

Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
American Cancer Society, Inc.

Recruiting

An Observational Pilot Study to Test a Smartwatch-based EMA Method During Exercise With Breast Cancer Survivors

Breast Cancer

United States
Montefiore Medical Center

Recruiting

Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Patients With ER+/HER2- Metastatic Breast Cancer

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center

Completed

The Prone to Supine Breast MRI Trial

Breast Cancer

United States
Gary Schwartz

Withdrawn

Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Experience of Arab American Women With Breast Cancer: In-depth Interviews

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center

Completed

A Study to Evaluate the Use of Supine MRI Images in Breast Conserving Surgery

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
Dartmouth College

Completed

Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue

Breast Cancer

United States
Tulane University Health Sciences Center
Novartis; Board of Regents, State of Louisiana

Withdrawn

ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer

Breast Cancer

United States
Yale University

Completed

Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial

Breast Cancer

United States
Koning Corporation
University of Rochester

Completed

Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring

Breast Cancer

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Participation Restrictions in Breast Cancer Survivors

Breast Cancer

United States
Rauscher, Gregory E., M.D. PA

Unknown

Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
The City College of New York; Ralph Lauren Center for Cancer Care and Prevention and other collaborators

Terminated

Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients

Breast Cancer

United States
Trinitas Comprehensive Cancer Center
Aptium Oncology Research Network

Unknown

Guided Relaxation Training for the Reduction of Self-Reported Stress in Individuals With Newly Diagnosed Breast Cancer (09-IM-01)

Breast Cancer

United States
GE Healthcare

Completed

Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram

Breast Cancer

United States
Fermiscan Ltd

Unknown

Use of Hair to Diagnose Breast Cancer

Breast Cancer

Australia
Advanced Endoscopy Research, Robert Wood Johnson...

Enrolling by invitation

Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study

Fistula | GERD | Gastroparesis | Achalasia | Gastric Outlet Obstruction | Reflux | Benign Neoplasm

United States
Columbia University
National Institute on Minority Health and Health Disparities (NIMHD)

Recruiting

Adherence Intervention in Patients With Metastatic Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Duke University

Completed

Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer (Excite)

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Genentech, Inc.; Amgen

Completed

Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Pharmacia

Completed

Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity

Breast Cancer

United States
Columbia University
National Cancer Institute (NCI)

Completed

Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting

Breast Neoplasm

United States
Memorial Sloan Kettering Cancer Center
Debiopharm International SA

Completed

A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer

Breast Cancer

United States
NYU Langone Health

Completed

Initial Assessment of 18FDG-PET/MRIin Determining the Extent of Systemic Disease in Breast Cancer Patients

Breast Cancer

United States
NYU Langone Health

Completed

Presurgical Trial of Denosumab in Breast Cancer

Breast Cancer

United States
Pfizer

Completed

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Breast Cancer

United States
Columbia University

Completed

CBPR - BRCA Genetic Testing Among Orthodox Jews

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer

Breast Cancer

United States

Clinical Trials on Benign Breast Findings in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations